Ionis Pharmaceuticals, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Regulation FD disclosureSep 23 →InsidersNo open-market buys. 19 insiders sold $124.2M, 93 of 120 sales on a 10b5-1 plan.→PeersClosest companies: VRTX, BIIB, LXRX→
From the filings
Figures
- Revenue
- $874.1Mlast 12 months
- Net income
- −$565.2Mlast 12 months
- Operating cash flow
- −$910.6Mlast 12 months
- Cash and equivalents
- $350.1Mat the last balance sheet
- Total debt
- $1.76Bat the last balance sheet
- Shares outstanding
- 165.6M shareson issue